Literature DB >> 11000528

Interactions between androgen and estrogen receptors and the effects on their transactivational properties.

V Panet-Raymond1, B Gottlieb, L K Beitel, L Pinsky, M A Trifiro.   

Abstract

The physiological interplay of androgen and estrogen action in endocrine tissues is well recognized. The biochemical processes responsible for this interplay have yet to be fully defined. We have demonstrated that the androgen receptor (AR) and estrogen receptor-alpha (ERalpha) can interact directly using the yeast and mammalian two-hybrid systems. These interactions occurred between the C-terminal ERalpha ligand-binding domain and either the N-terminal AR transactivational domain or the full-length AR. Estrogen receptor-beta (ERbeta) did not interact with the AR. DNA cotransfection studies employing AR, ERalpha and ERbeta expression vectors and AR- or ER-reporter gene constructs were used to identify and measure potential functional effects of AR-ER interaction. Coexpression of ERalpha with AR decreased AR transactivation by 35%; coexpression of AR with ERalpha decreased ERalpha transactivation by 74%. Coexpression of AR and ERbeta did not significantly modulate AR or ERbeta transactivation. In summary, we have shown that specific domains of AR and ERalpha physically interact and have demonstrated the functional consequences of such interaction. These results may help explain the nature of the physiological interplay between androgens and estrogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000528     DOI: 10.1016/s0303-7207(00)00279-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  59 in total

Review 1.  Targeting the androgen receptor in prostate and breast cancer: several new agents in development.

Authors:  Tracy Proverbs-Singh; Jarett L Feldman; Michael J Morris; Karen A Autio; Tiffany A Traina
Journal:  Endocr Relat Cancer       Date:  2015-02-26       Impact factor: 5.678

2.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

3.  Expression of androgen receptor and its co-localization with estrogen receptor-alpha in the developing pituitary gland of sheep fetus.

Authors:  XueJun Yuan; YuQin He; JiaLi Liu; HaoShu Luo; JinHua Zhang; Sheng Cui
Journal:  Histochem Cell Biol       Date:  2007-01-05       Impact factor: 4.304

4.  Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer.

Authors:  Aristomenis Anestis; Panagiotis Sarantis; Stamatios Theocharis; Ilianna Zoi; Dimitrios Tryfonopoulos; Athanasios Korogiannos; Anna Koumarianou; Evangelia Xingi; Dimitra Thomaidou; Michalis Kontos; Athanasios G Papavassiliou; Michalis V Karamouzis
Journal:  J Cancer Res Clin Oncol       Date:  2019-02-25       Impact factor: 4.553

5.  Current Biomarkers for Precision Medicine in Breast Cancer.

Authors:  Soo Kyung Ahn; So-Youn Jung
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor.

Authors:  Yun Teng; Lacey M Litchfield; Margarita M Ivanova; Russell A Prough; Barbara J Clark; Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2014-05-17       Impact factor: 4.102

7.  Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.

Authors:  Jan-Hendrik Bebermeier; James D Brooks; Samuel E DePrimo; Ralf Werner; Uta Deppe; Janos Demeter; Olaf Hiort; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2006-08-24       Impact factor: 4.599

Review 8.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

9.  Cooperative Dynamics of AR and ER Activity in Breast Cancer.

Authors:  Nicholas C D'Amato; Michael A Gordon; Beatrice Babbs; Nicole S Spoelstra; Kiel T Carson Butterfield; Kathleen C Torkko; Vernon T Phan; Valerie N Barton; Thomas J Rogers; Carol A Sartorius; Anthony Elias; Jason Gertz; Britta M Jacobsen; Jennifer K Richer
Journal:  Mol Cancer Res       Date:  2016-08-26       Impact factor: 5.852

Review 10.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Authors:  T E Hickey; J L L Robinson; J S Carroll; W D Tilley
Journal:  Mol Endocrinol       Date:  2012-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.